Juliana E. Parente

Doctora en Química
Profesora Adjunta
Jefa de Trabajos Prácticos
Ayudante Diplomada
Investigadora UNLP
Investigadora Asistente Asociada a CICPBA

 


Proyectos de Investigación


Formación de Recursos Humanos

Directora de:


Publicaciones

Año 2021
  • N. Martini, J. E. Parente, G. Restrepo-Guerrero, C. A. Franca, O. E.Piro, G. A. Echeverría, P. A.M. Williams, E. G. Ferrer. Tetraacuo-bis-(N,N-dimethylacetamide-O)magnesium(II) chloride dihydrate. An option to improve magnesium effect on phosphatase stimulation and albumin binding. Journal of Molecular Structure, 2021, 1223, 129240. DOI: 10.1016/j.molstruc.2020.129240
Año 2019
  • N. Martini, J. E. Parente, M. E. Toledo, G. E. Escudero, C.H. Laino, O.E. Piro, G. Etcheverría, P. A. M. Williams, E.G. Ferrer.
    Antidepressant and antinociceptive activities in animal models and in vitro assessment of the anti-thyroid activity of bis(DL-pyroglutamate)magnesium complex. Pharmacological Reports, 2019, 71, 6, 1273-1280. DOI: 10.1016/j.pharep.2019.07.009
  • J. E. Parente, L. G. Naso, K. Jori, C. A. Franca, A. M. da Costa Ferreira, P. A. M. Williams, E. G. Ferrer.
    In vitro experiments and infrared spectroscopy analysis of acid and alkaline phosphatase inhibition by vanadium complexes.
    New Journal of Chemistry, 2019, Advance Article. DOI: 10.1039/C9NJ01638D
  • N. Martini, J. E. Parente, F. D'Alessandro, M. Rey, A. Rizzi, P. A. M. Williams, E. G. Ferrer.
    Potential bio-protective effect of copper compounds: mimicking SOD and peroxidases enzymes and inhibiting acid phosphatase as a target for anti-osteoporotic chemotherapeutics. Molecular Biology Reports, 2019, 46, 867–885. DOI: 10.1007/s11033-018-4542-8
  • J. E. Parente, P. A. M. Williams, E. G. Ferrer.
    Vanadium Compounds as Biocatalyst Models. Biological Trace Element Research, 2019, 1-7. DOI: 10.1007/s12011-019-01874-5
Año 2018
  • L. L. Soprano, J. E. Parente, M. Landoni, A. S. Couto, V. G. Duschak. Trypanosoma cruzi serinecarboxipeptidase is a sulfated glycoprotein and a minor antigen in human Chagas disease infection. Medical Microbiology and Immunology, 2018, 207, 2, 117-128. DOI: 10.1007/s00430-017-0529-7
Año 2017
  • N. Martini, J.E. Parente, M.E. Toledo, G.E. Escudero, C.H. Laino, J.J. Martínez Medina, G.A. Echeverría, O.E. Piro, L. Lezama, P.A.M. Williams, E.G. Ferrer. Evidence of promising biological-pharmacological activities of the sertraline-based copper complex: (SerH2)2[CuCl4]. Journal of Inorganic Biochemistry, 2017,174, 76-89. DOI: 10.1016/j.jinorgbio.2017.05.012